X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemotherapy (10) 10
eurtac (10) 10
gefitinib (9) 9
index medicus (8) 8
humans (7) 7
lung neoplasms - drug therapy (7) 7
carcinoma, non-small-cell lung - drug therapy (6) 6
female (6) 6
lung neoplasms - genetics (6) 6
male (6) 6
oncology (6) 6
adenocarcinoma (5) 5
aged (5) 5
carcinoma, non-small-cell lung - genetics (5) 5
erlotinib (5) 5
receptor, epidermal growth factor - genetics (5) 5
survival (5) 5
trial (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
lung cancer, non-small cell (4) 4
middle aged (4) 4
respiratory system (4) 4
survival analysis (4) 4
cell lung-cancer (3) 3
disease-free survival (3) 3
epidermal growth factor receptor (3) 3
erlotinib hydrochloride - therapeutic use (3) 3
genetic aspects (3) 3
growth-factor receptor (3) 3
lung cancer (3) 3
mutation (3) 3
mutations (3) 3
open-label (3) 3
protein kinase inhibitors - therapeutic use (3) 3
receptor, epidermal growth factor - antagonists & inhibitors (3) 3
treatment outcome (3) 3
afatinib (2) 2
antineoplastic agents - therapeutic use (2) 2
carboplatin - therapeutic use (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
circulating free dna (2) 2
deoxycytidine - analogs & derivatives (2) 2
deoxycytidine - therapeutic use (2) 2
egfr mutations (2) 2
epidermal growth factor (2) 2
health aspects (2) 2
lung cancer, small cell (2) 2
lung neoplasms - mortality (2) 2
lung neoplasms - pathology (2) 2
metastasis (2) 2
multicenter (2) 2
mutation - genetics (2) 2
non-small cell lung cancer (2) 2
non-small-cell lung cancer (2) 2
nsclc (2) 2
plasma (2) 2
prognosis (2) 2
protein kinase inhibitors - adverse effects (2) 2
research (2) 2
respiratory tract diseases (2) 2
therapy (2) 2
1st-line therapy (1) 1
adult (1) 1
aged, 80 and over (1) 1
analysis (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
apoptosis - genetics (1) 1
apoptosis regulatory proteins - genetics (1) 1
apoptosis regulatory proteins - metabolism (1) 1
article (1) 1
asian (1) 1
asian continental ancestry group (1) 1
bcl-2-like protein 11 (1) 1
bevacizumab - administration & dosage (1) 1
bim protein (1) 1
biochemistry, genetics and molecular biology (1) 1
biomarkers, tumor (1) 1
braf (1) 1
brain metastases (1) 1
brca1 (1) 1
cancer (1) 1
cancer patients (1) 1
cancer therapies (1) 1
carboplatin - adverse effects (1) 1
carboplatin-paclitaxel (1) 1
care and treatment (1) 1
case report (1) 1
cell (1) 1
cell activation (1) 1
cell biology (1) 1
cell proliferation (1) 1
circulating tumor dna - analysis (1) 1
cohort studies (1) 1
critical care medicine (1) 1
deoxycytidine - adverse effects (1) 1
deoxyribonucleic acid--dna (1) 1
development and progression (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 5, pp. 435 - 444
Journal Article
by Zhou, Caicun and Wu, Y.L and Chen, G and Feng, J and Liu, X.-Q and Wang, C and Zhang, S and Wang, J and Zhou, S and Ren, S and Lu, S and Zhang, L and Hu, C and Hu, C and Luo, Y and Chen, L and Ye, M and Huang, J and Zhi, X and Zhang, Y and Xiu, Q and Ma, J and Zhang, L and You, C
Annals of Oncology, ISSN 0923-7534, 09/2015, Volume 26, Issue 9, pp. 1877 - 1883
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2015, Volume 5, Issue 1, p. 17499
BIM is a proapoptotic protein that initiates apoptosis triggered by EGFR tyrosine kinase inhibitors (TKI). mTOR negatively regulates apoptosis and may... 
APOPTOSIS | THERAPY | MESSENGER-RNA EXPRESSION | EURTAC | MULTIDISCIPLINARY SCIENCES | KINASE | MUTATIONS | BRCA1 | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Humans | Middle Aged | Apoptosis - genetics | Lung Neoplasms - pathology | Male | RNA, Messenger - metabolism | TOR Serine-Threonine Kinases - genetics | Bcl-2-Like Protein 11 | Apoptosis Regulatory Proteins - genetics | Inhibitory Concentration 50 | Female | Membrane Proteins - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Membrane Proteins - genetics | RNA, Messenger - genetics | Proto-Oncogene Proteins - genetics | Treatment Outcome | Signal Transduction - genetics | Mutation - genetics | Apoptosis Regulatory Proteins - metabolism | Disease-Free Survival | Signal Transduction - drug effects | Quinazolines - therapeutic use | Erlotinib Hydrochloride - pharmacology | Aged | Erlotinib Hydrochloride - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Quinazolines - pharmacology | Cohort Studies | Tyrosine | TOR protein | Cell proliferation | Adenocarcinoma | Epidermal growth factor receptors | Lung cancer | Non-small cell lung carcinoma | Tumor cell lines | Gene expression | Kinases | Cell activation | Gefitinib | Protein-tyrosine kinase | BIM protein | Apoptosis | Phosphodiesterase
Journal Article
by Wu, Yi-Long and Zhou, C and Liam, C.-K and Wu, G and Liu, X and Zhong, Z and Lu, S and Cheng, Y and Han, B and Chen, L and Huang, C and Qin, S and Zhu, Y and Pan, H and Liang, H and Li, E and Jiang, G and How, S.H and Fernando, M.C.L and Zhang, Y and Xia, F and Zuo, Y
Annals of Oncology, ISSN 0923-7534, 09/2015, Volume 26, Issue 9, pp. 1883 - 1889
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.